Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Revenue
Beijing Hotgen Biotech Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Revenue
¥3.6B
|
CAGR 3-Years
157%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Revenue
¥40.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Revenue
¥11.5B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Revenue
¥17B
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Revenue
¥7.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
36%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Revenue
¥990.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Revenue?
Revenue
3.6B
CNY
Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Revenue amounts to 3.6B CNY.
What is Beijing Hotgen Biotech Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
90%
Over the last year, the Revenue growth was -34%. The average annual Revenue growth rates for Beijing Hotgen Biotech Co Ltd have been 157% over the past three years , 90% over the past five years .